CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Without a doubt, one of the most (if not the most) crucial search engine optimization (SEO) activities is keyword research—specifically finding the right keywords. But keyword research can take a lot ...
AI companies’ need for a once obscure and affordable type of microchip threatens to drive up prices of all electronics—and limit data-center ambitions. The opportunity for everyday folks to enhance ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...